Large-scale expansion of CD3(+)CD56(+) lymphocytes capable of lysing autologous tumor cells with cytokine-rich supernatants (original) (raw)
A new method for in vitro expansion of cytotoxic human CD3−CD56+ natural killer cells
Stefan Carlens
Human Immunology, 2001
View PDFchevron_right
Induction of anti-tumour lymphocytes in cancer patients after brief exposure to supernatants from cultures of anti-CD3-stimulated allogeneic lymphocytes
Gregory Spanakos
British journal of cancer, 1997
View PDFchevron_right
Expansion of cytotoxic natural killer cells using irradiated autologous peripheral blood mononuclear cells and anti-CD16 antibody
Eun-kyoung Koh
Scientific Reports
View PDFchevron_right
Expansion of allogeneic NK cells with efficient antibody-dependent cell cytotoxicity against multiple tumors
Amelie Cornillon
Theranostics
View PDFchevron_right
Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
Xianzhi Jiang
View PDFchevron_right
Cell-Mediated Cytotoxicity Killing and Activation of NK Dendritic Cells: Direct Tumor Cell Tumoricidal Potential of Native Blood
Senming Zhao
2000
View PDFchevron_right
Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells
Abdul Tawab
Cytotherapy, 2009
View PDFchevron_right
In vitromodulation of natural killer activity of human peripheral blood mononuclear cells against prostate tumor cell line
Abdolkarim Sheikhi
Immunopharmacology and Immunotoxicology, 2011
View PDFchevron_right
Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a phase I clinical study
Gunnar Soderdahl
Immunotherapy, 2009
View PDFchevron_right
Ex Vivo Expansion of Highly Cytotoxic Human NK Cells by Cocultivation with Irradiated Tumor Cells for Adoptive Immunotherapy
Chung-Hee Sonn
Cancer Research, 2013
View PDFchevron_right
Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours
John Hassell, Craig Aarts
View PDFchevron_right
Cytostatic and cytotoxic activity of lymphokine-activated killer cell supernatants
Jacqueline Brailey
Cancer Immunol Immunother, 1989
View PDFchevron_right
A CD16/CD30 bispecific monoclonal antibody induces lysis of hodgkin's cells by unstimulated natural killer cellsIn ANDIn vivo
Ugur Sahin
International Journal of Cancer, 1993
View PDFchevron_right
Influence of tumor cells on natural killer cell phenotype and cytotoxicity
Aikyn Kali
International Journal of Biology, 2015
View PDFchevron_right
Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56brightCD16− cells and display an impaired capability to kill tumor cells
Guido Frumento
Cancer, 2008
View PDFchevron_right
Cytotoxic functions and susceptibility to apoptosis of human CD56bright NK cells differentiated in vitro from CD34+ hematopoietic progenitors
Flavia Buccella, Barbara Canonico, Genny Del Zotto
Cytometry Part A, 2012
View PDFchevron_right
High Log-Scale Expansion of Functional Human Natural Killer Cells from Umbilical Cord Blood CD34-Positive Cells for Adoptive Cancer Immunotherapy
Arnold van der Meer
PLoS ONE, 2010
View PDFchevron_right
Selective Expansion of Human Natural Killer Cells from Peripheral Blood Mononuclear Cells by the Cell Line, HFWT
Frank Preijers
Japanese Journal of Cancer Research, 2002
View PDFchevron_right
Preparation of Cytokine-activated NK Cells for Use in Adoptive Cell Therapy in Cancer Patients
Henk-Jan Prins
Journal of Immunotherapy, 2016
View PDFchevron_right
Validation of the CliniMACS prodigy for manufacture of tumor-primed natural killer cells (TpNK)
Mark Lowdell
Cytotherapy, 2015
View PDFchevron_right
Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2
Yael Kaufmann
Cancer research, 1984
View PDFchevron_right
Autologous Natural Killer Cell-enrichment for Immune Cell Therapy: Preclinical Setting Phase, Shiraz Experience
somayeh Rezaeifard
Iranian Journal of Allergy, Asthma and Immunology, 2021
View PDFchevron_right
Natural Killer Cell Expansion with Autologous Feeder Layer and Anti-CD3 Antibody for Immune Cell Therapy of Hepatocellular Carcinoma
javad verdi
Asian Pacific Journal of Cancer Prevention, 2019
View PDFchevron_right
Cytotoxicity of Human Hepatic Intrasinusoidal CD56bright Natural Killer Cells against Hepatocellular Carcinoma Cells
Eunyoung Tak
International Journal of Molecular Sciences, 2019
View PDFchevron_right
Artificial feeder cells expressing ligands for killer cell immunoglobulin-like receptors and CD94/NKG2A for expansion of functional primary natural killer cells with tolerance to self
Monika Füssel
Cytotherapy, 2020
View PDFchevron_right
Cytolytic activity and regulatory functions of inhibitory NK cell receptor–expressing T cells expanded from granulocyte colony-stimulating factor–mobilized peripheral blood mononuclear cells
Masanobu Kobayashi
Blood, 2004
View PDFchevron_right
Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment
Der-Yang Cho
Journal of Visualized Experiments, 2020
View PDFchevron_right
Role of Natural Killer Cells on Engraftment of Human Lymphoid Cells and on Metastasis of Human T-Lymphoblastoid Leukemia Cells in C57BL/6J-scidMice and in …
Gillian Beamer
Cellular …, 1996
View PDFchevron_right
Identification of Anti-tumor Cells Carrying Natural Killer (NK) Cell Antigens in Patients With Hematological Cancers
Amelie Cornillon
EBioMedicine, 2015
View PDFchevron_right
Cancer Immunotherapy with Cytokine-Induced Killer Cells
Mayara de Oliveira Ribeiro
Targeted Oncology, 2017
View PDFchevron_right
Target cell induced activation of NK cells in vitro: cytokine production and enhancement of cytotoxic function
Suvendu Das
Cancer Immunology Immunotherapy, 2001
View PDFchevron_right
Evidence for the involvement of CD56 molecules in alloantigen-specific recognition by human natural killer cells
Noboru Suzuki
Journal of Experimental Medicine, 1991
View PDFchevron_right